Our 15 finalists for the 2020 $200K Challenge have innovative, lifesaving ideas. While we wait for a safer time to reschedule the Challenge, we will continue to share our finalists’ life sciences innovations.
$200K Challenge Finalist CranioSense is developing IPASS, a medical device for noninvasive assessment of intracranial pressure (ICP), a critical parameter in traumatic brain injury (TBI) and other medical conditions affecting the brain. We talked with CEO Gordon Hirschman about what brought them to their innovation and the 2020 $200K Challenge.
As we wait for a safer time to reschedule the 2020 $200K Challenge events, we want to share our Finalists’ new, lifesaving ideas.
$200K Challenge Amachumu Bio is a socially minded, globally focused company working to create healthier and more productive communities by curing 1.5 billion people and food and companion animals of intestinal parasitic worms. We talked with CEO Meghan Doyle and founder Raffi Aroian about their company’s history and their innovative food supplement that aims to address the problem.
Two years ago, Cam Med Inc. was a Finalist in the 2018 M2D2 $200K Challenge. Since then, Cam Med’s cofounders, CEO Larry Alberts and CTO Zhifei Ge have been the very model of “seize every opportunity” startup leaders, taking advantage of virtually every chance for learning, mentoring, financing, and networking that’s come their way. The result has been a steady upward trajectory for their innovation: the Evopump, a wearable on-body delivery system for injectable drugs.
M2D2 is excited and proud to share the news that Hememics Biotechnologies, Inc. has secured U.S. government funding from the Biomedical Advanced Research and Development Authority (BARDA) for the advancement of a COVID-19 rapid test.
In March, we chose 15 innovative startups as M2D2 $200K Challenge Finalists for 2020. While we have had to postpone the Challenge events in response to the COVID-19 pandemic, we don’t want to wait to share our Finalists’ new, lifesaving ideas.
$200K Challenge Finalist Arrow Diagnostics, Inc. is working towards non-invasive solutions for early screening of non-alcoholic fatty liver disease. We talked to Edward Olano, co-founder and CEO, about their history and their innovation.
We’re not letting a pandemic get between you and the expertise you need to advance your idea. In fact we’re now able to connect anyone with life sciences advisors with Virtual Office Hours.
Starting Tuesday, April 14th, our Insider Advisors will begin hosting Virtual Office Hours using Zoom. Leading off will be Jeff Champagne from MPR and Barry Sands from RQMIS, Inc. Throughout the coronavirus emergency, we will coordinate with our other life sciences advisors so we can continue to offer startups a broad range of expertise and assistance.
15 finalists have been selected from more than 250 applicants for the 9th Annual M2D2 $200K Challenge. This year’s participation sets a new record for the competition!
LOWELL, Massachusetts – The University of Massachusetts Medical Device Development Center (M2D2) today announced the finalists in its 9th annual $200K Challenge after reviewing a record-setting 250+ applications.
Last April, UroMonitor, a wireless, insertable pressure sensor to assist in the diagnosis of urinary incontinence, was named a first-place winner at the 8th annual M2D2 $200K Challenge. Led by device creator Professor Margot Damser, Ph.D., of the Cleveland Clinic’s Lerner Research Institute, UroMonitor won the first Hologic Award as well. With the 2020 Challenge right around the corner, we checked in with Margot to see what’s happened with her innovation over the last year.
The Center for Advancing Point of Care Technologies (CAPCaT) is actively searching for point-of-care technologies that can be applied to heart, lung, blood or sleep disorders. Entrepreneurs (from anywhere in the world) whose inventions are approaching the clinical testing phase are encouraged to apply for point-of-care grant awards of up to $100,000. The Expression of Interest deadline is Monday, March 2 at 4:59 pm EST.
We were delighted to see an SRO crowd of approximately 100
people at our Venture Funding Happy Hour on February 4. This event provided a
way for local life science business financing experts to share their expertise
with startups. While they offered countless pieces of important advice, the
four speakers continued to hammer on one very key piece of information: You
need both the science AND someone with the business smarts.